![]() | |
Clinical data | |
---|---|
Other names | 3,4-Ethylenedioxyamphetamine; EDA; EDA-6; α-Methyl-1,4-benzodioxan-6-ethylamine |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C11H15NO2 |
Molar mass | 193.246 g·mol−1 |
3D model (JSmol) | |
| |
|
3,4-Ethylenedioxyamphetamine (EDA), also known as EDA-6, is a drug of the amphetamine family related to 3,4-methylenedioxyamphetamine (MDA). [1] It is closely related to analogues including 3,4-ethylenedioxymethamphetamine (EDMA), 3,4-ethylidenedioxyamphetamine (EIDA), and 3,4-isopropylidenedioxyamphetamine (IDA). [1] [2] EDMA, the N-methylated analogue of EDA, is known to be a serotonin–norepinephrine–dopamine releasing agent (SNDRA). [3] According to Alexander Shulgin however, the drug only produced limited psychoactive effects in humans at doses in the range of 150 to 250 mg. [4] [1]
Phenethylamines |
| ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amphetamines |
| ||||||||||||||||
Phentermines |
| ||||||||||||||||
Cathinones |
| ||||||||||||||||
Phenylisobutylamines (and further-extended) | |||||||||||||||||
Catecholamines (and close relatives) |
| ||||||||||||||||
Cyclized phenethylamines |
| ||||||||||||||||
Related compounds |
| ||||||||||||||||
Stimulants |
|
---|---|
Depressants |
|
Hallucinogens |
|
Entactogens |
|
Psychiatric drugs |
|
Others |
|
![]() | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |